{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:53:54Z","timestamp":1778853234427,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","transplantation-proceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.transproceed.2015.09.006","type":"journal-article","created":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T10:26:38Z","timestamp":1445941598000},"page":"2364-2367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mammalian Target of Rapamycin Inhibitor Monotherapy: Efficacy in Renal Transplantation"],"prefix":"10.1016","volume":"47","author":[{"given":"A.","family":"Franco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"M\u00e1s-Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Perez Contreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Olivares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2015.09.006_bib1","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1600-6143.2006.01270.x","article-title":"Immunosuppression: evolution in practice and trends, 1994-2004","volume":"6","author":"Meier-Kriesche","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2015.09.006_bib2","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1600-6143.2004.00332.x","article-title":"Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era","volume":"4","author":"Meier-Kriesche","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2015.09.006_bib3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/01.tp.0000235527.81917.fe","article-title":"Cardiovascular complications after renal transplantation and their prevention","volume":"82","author":"Ojo","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2015.09.006_bib4","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"Nankivell","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2015.09.006_bib5","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.296.23.2823","article-title":"Cancer incidence before and after kidney transplantation","volume":"296","author":"Vajdic","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.transproceed.2015.09.006_bib6","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1681\/ASN.2008111186","article-title":"The role of the mammalian target of rapamycin (m-Tor) in renal disease","volume":"20","author":"Lieberthal","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2015.09.006_bib7","doi-asserted-by":"crossref","first-page":"g6679","DOI":"10.1136\/bmj.g6679","article-title":"Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data","volume":"349","author":"Knoll","year":"2014","journal-title":"BMJ"},{"issue":"Suppl 3","key":"10.1016\/j.transproceed.2015.09.006_bib8","first-page":"S1","article-title":"KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2015.09.006_bib9","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1093\/ndt\/gfl338","article-title":"Retrospective analysis of surgical complications following cadaveric kidney transplantation in the modern transplant era","volume":"21","author":"Hern\u00e1ndez","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2015.09.006_bib10","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/ajt.12795","article-title":"A\u00a0systematic review of conversion from calcineurin inhibitor to mammalian target of rapamycin inhibitors for maintenance immunosuppression in kidney transplant recipients","volume":"14","author":"Lim","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2015.09.006_bib11","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1111\/j.1600-6143.2007.01842.x","article-title":"Contrasting effects of cyclosporine and rapamycin in the novo generation of alloantigen-specific regulatory T cells","volume":"7","author":"Gao","year":"2007","journal-title":"Am J Transplant"},{"issue":"8 Suppl","key":"10.1016\/j.transproceed.2015.09.006_bib12","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/TP.0b013e3181a07b08","article-title":"Inhibitors of the mammalian target of rapamycin and transplant tolerance","volume":"87","author":"Bestard","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2015.09.006_bib13","first-page":"405","article-title":"Comparative analysis of drug action on B-Cell proliferation and differentiation for mycophenolic acid, everolimus, and prednisolone","volume":"97","author":"Haneda","year":"2014","journal-title":"Transplantation"},{"issue":"8 Suppl","key":"10.1016\/j.transproceed.2015.09.006_bib14","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/TP.0b013e3181a05b7a","article-title":"Management of side effects of sirolimus therapy","volume":"87","author":"Stallone","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2015.09.006_bib15","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1016\/j.transproceed.2010.09.074","article-title":"Increased adherence after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation: a pre-experimental study","volume":"42","author":"Doesch","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2015.09.006_bib16","first-page":"488","article-title":"Conversion from calcineurin inhibitors to sirolimus in chronic allograft disfunction: changes in glomerular haemodinamics and proteinuria","volume":"2","author":"Jaurina","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"3S","key":"10.1016\/j.transproceed.2015.09.006_bib17","article-title":"Effect of ramipril on urinary protein excretion in maintenance renal transplant patients converted to sirolimus","volume":"14","author":"Mandelbrot","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2015.09.006_bib18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1432-2277.2009.00983.x","article-title":"Sirolimus monotherapy as maintenance immunosuppression: a multicenter experience","volume":"23","author":"Pinto","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2015.09.006_bib19","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1016\/j.transproceed.2010.07.083","article-title":"Comparative analysis of adverse events requiring suspension of mTOR inhibitors: everolimus versus sirolimus","volume":"42","author":"S\u00e1nchez-Fructuoso","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2015.09.006_bib20","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1111\/ajt.12852","article-title":"Risk of metabolic complications in kidney transplantation after conversion to m-TOR inhibitors: a systematic review and meta-analysis","volume":"14","author":"Murakami","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2015.09.006_bib21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/TP.0b013e3181927a41","article-title":"Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial","volume":"87","author":"Schena","year":"2009","journal-title":"Transplantation"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134515008581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134515008581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T06:55:16Z","timestamp":1537253716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134515008581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0041134515008581"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2015.09.006","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mammalian Target of Rapamycin Inhibitor Monotherapy: Efficacy in Renal Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2015.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}